Search In this Thesis
   Search In this Thesis  
العنوان
Risk Factors for Venous Thromboembolism (VTE) /
المؤلف
Abo El-Hassan, Ahmed El-Sayed.
هيئة الاعداد
باحث / أحمد السيد حسن أبو الحسن
مشرف / هشام شفيق أبو جريدة
مشرف / محمود سعيد الدسوقي
مشرف / وليد محمد عمران
الموضوع
Geriatrics. Gerontology.
تاريخ النشر
2017.
عدد الصفحات
163 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
جراحة
الناشر
تاريخ الإجازة
1/3/2017
مكان الإجازة
جامعة المنوفية - كلية الطب - الجراحة العامة
الفهرس
Only 14 pages are availabe for public view

from 163

from 163

Abstract

Several risk factors for DVT were identified in patients presenting with, and their comprehension may improve appropriateness and efficiency of the different methods available for thromboprophylaxis.
An improved understanding of the epidemiology and risk factors for first and recurrent venous thrombosis can translate to improved clinical outcomes in practice. Consideration of risk factors can allow optimal use of prophylactic strategies against venous thrombosis.
Continuous education and appraisals in order to elevate VTE awareness, to implement tools for identification of at risk population and to improve adherence to the evidence-based VTE prophylaxis strategies, could help preventing this potentially fatal condition.
The knowledge and identification of VTE risk factors have important implications for the development of strategies for primary and secondary prevention of venous thrombosis. This study provides new data on the common VTE risk factors in a large cohort of patients with a first or recurrent VTE.
Future research should be directed towards identification of the optimal targets for VTE prophylaxis.
Groups currently considered to be at high risk of VTE, such as all patients undergoing hip or knee replacement surgery, include few individuals who would experience VTE in the absence of prophylaxis. The requirement is to identify the individuals within these groups who are at high risk of incident or recurrent VTE, who would benefit most from primary or secondary prophylaxis, thereby minimizing the risk of bleeding complications incurred by treatment of those at low risk.